Johnson & Johnson

JNJNYSE · USD
271.22USD0.00 (+0.20%)
6710

Johnson & Johnson (JNJ) Implied Volatility Current

JNJ implied volatility is 27%. IV Rank is 83%, placing current premiums in the top of their 52-week range.

Read more

Tracking JNJ implied volatility helps you identify when options premiums on Johnson & Johnson are historically cheap or expensive, and where the best trades are hiding. Johnson & Johnson implied volatility reflects the market's expectation of future price movement: when JNJ IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Johnson & Johnson's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For JNJ, tracking metrics like JNJ IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on JNJ signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand.

Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where JNJ implied volatility sits today versus where it has been. Our scanner ranks Johnson & Johnson implied volatility against its historical range, surfaces extremes in JNJ IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Johnson & Johnson IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
83.33%IV Rank
High

IV is near its yearly peak - premiums are expensive, favoring sellers.

Implied Volatility (30d)26.63%

IV Rank83.33%

Historical Volatility (30d)18.85%

IV - HV+7.78%

As of September 25, 2026

Trade options with IV on your side

Track JNJ IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial